Medpace Quarterly Balance Sheet
NASDAQ: MEDPHealthcareDiagnostics & ResearchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Medpace financial position
As of Jun 30, 2026, Medpace reported total assets of $2.06 billion, up 30.9% from a year earlier against total liabilities of $1.62 billion. Shareholders' equity stood at $433.9 million, or 21.1% of assets. The company held $502.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 0.73, meaning short-term obligations exceed short-term assets.
Summary generated from market data by MetaCap's automated system. Methodology
Medpace balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 502.69M | 652.68M | 497.05M | 285.35M | 46.33M | 441.44M | 669.44M | 656.90M | 510.89M | 407.01M | 245.45M | 95.21M |
| Receivables | 441.80M | 394.58M | 402.08M | 373.03M | 377.92M | 298.22M | 296.44M | 311.47M | 301.11M | 279.17M | 298.40M | 292.77M |
| Total Current Assets | 1.05B | 1.14B | 989.62M | 737.28M | 520.80M | 821.44M | 1.03B | 1.03B | 872.52M | 744.90M | 593.83M | 448.88M |
| Property, Plant & Equipment | 157.11M | 136.55M | 131.06M | 133.18M | 135.48M | 128.33M | 123.61M | 124.06M | 122.39M | 118.60M | 120.59M | 114.76M |
| Goodwill | 662.40M | 662.40M | 662.40M | 662.40M | 662.40M | 662.40M | 662.40M | 662.40M | 662.40M | 662.40M | 662.40M | 662.40M |
| Intangible Assets | 33.11M | 33.27M | 33.42M | 33.66M | 33.89M | 34.13M | 34.37M | 34.73M | 35.09M | 35.45M | 35.81M | 36.36M |
| Total Assets | 2.06B | 2.13B | 1.98B | 1.75B | 1.57B | 1.90B | 2.10B | 2.08B | 1.92B | 1.80B | 1.66B | 1.49B |
| Accounts Payable | 37.53M | 34.43M | 28.14M | 26.52M | 43.27M | 61.32M | 32.53M | 26.20M | 27.39M | 24.40M | 31.87M | 29.02M |
| Short-Term Debt | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Total Current Liabilities | 1.44B | 1.35B | 1.34B | 1.28B | 1.22B | 1.12B | 1.10B | 1.04B | 993.09M | 956.64M | 925.13M | 848.52M |
| Total Liabilities | 1.62B | 1.53B | 1.52B | 1.46B | 1.40B | 1.30B | 1.28B | 1.20B | 1.16B | 1.12B | 1.10B | 1.02B |
| Shareholders' Equity | 433.86M | 598.31M | 459.07M | 293.64M | 172.35M | 593.61M | 825.54M | 881.44M | 763.60M | 671.54M | 558.95M | 470.91M |
| Retained Earnings | -511.37M | -336.11M | -459.98M | -596.24M | -703.22M | -269.72M | 8.17M | 65.64M | -30.79M | -119.14M | -221.65M | -300.20M |
| Total Debt | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Net Cash (Debt) | 502.69M | 652.68M | 497.05M | 285.35M | 46.33M | 441.44M | 669.44M | 656.90M | 510.89M | 407.01M | 245.45M | 95.21M |
| Shares Outstanding | 27.91M | 28.56M | 28.37M | 28.17M | 28.09M | 29.84M | 30.63M | 31.08M | 31.00M | 30.98M | 30.75M | 30.68M |
This table shows 12 quarterly periods of Medpace's balance sheet, from Q2 2026 back to Q3 2023, across 17 line items including cash & equivalents, receivables, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow MEDP's reporting calendar. What is a balance sheet?